Ilika plc (LON: IKA), an independent global expert in solid-state battery technology, has announced that it has appointed Cavendish Capital Markets Limited as Nominated Adviser and Sole Broker with immediate effect.
Ilika appoints Cavendish Capital Markets as Nominated Adviser and Sole Broker
- Written by: Amilia Stone
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.
Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.
Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.
Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.
Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.
